Musculoskeletal adverse events associated with CDK4/6 inhibitors: a real-world study using FDA Adverse Event Reporting System (FAERS) database
Musculoskeletal toxicities is a significant adverse event that affects drug safety. Early identification and proper management of these events are crucial for patients receiving CDK4/6 inhibitors. Further research is warranted to elucidate the underlying mechanisms and improve risk mitigation strategies.
Authors
- Zhiwen Fu (ORCID: https://orcid.org/0000-0002-0635-1368)
- Wei Chen (ORCID: https://orcid.org/0009-0007-4260-1794)
- Zhang Nu
- Zhen-Lin Chen (ORCID: https://orcid.org/0000-0002-4075-4128)
- Wen‐Bin Zou
Institutions
- Union Hospital (HK)
- Jianghan University (CN)
- Wuhan Science and Technology Bureau (CN)
- Fujian Provincial People's Hospital (CN)
- Wuhan Union Hospital (CN)
- Tongji Hospital (CN)
- Union Hospital (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- BMC Pharmacology and Toxicology
- Published
- 2025-01-29
- DOI
- https://doi.org/10.1186/s40360-025-00862-x
- Citations
- 2
- Primary Topic
- Advanced Breast Cancer Therapies
- Type
- article
- Field-Weighted Citation Impact
- 3.04